About Sol Barer, Ph.D.
Form D filings for Centrexion Therapeutics from 2023 to 2024 list Sol Barer, Ph.D. as director.
Sol Barer, Ph.D. first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Sol Barer, Ph.D. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sol Barer, Ph.D. works with at each company, as listed on that company's latest Form D.
Centrexion Therapeutics Corp · Form D, Jan 8, 2024
ST
Shawn Tomasello
Director
MW
Michael Ward
Chief Financial Officer, Treasurer, and Secretary
JD
James Campbell, M.D.
Executive officer and director
CH
Colin Hill
Director
RS
Randall Stevens
Executive officer
JS
Joseph Swedish
Director
JK
Jeffrey Kindler
Executive officer and director
JD
J.c. Lopez, M.D.
Director